| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPP | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | LDLRAD4 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | ZNF326 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | MGAT5B | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | SEC14L3 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | WDR75 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | CCDC102A | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | ZNF84 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | TPMT | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | ATP1A4 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
